SE392274B - Forfarande for framstellning av indol- och indenderivat med verdefulla terapeutiska egenskaper och med lag toxicitet - Google Patents

Forfarande for framstellning av indol- och indenderivat med verdefulla terapeutiska egenskaper och med lag toxicitet

Info

Publication number
SE392274B
SE392274B SE7300471A SE7300471A SE392274B SE 392274 B SE392274 B SE 392274B SE 7300471 A SE7300471 A SE 7300471A SE 7300471 A SE7300471 A SE 7300471A SE 392274 B SE392274 B SE 392274B
Authority
SE
Sweden
Prior art keywords
indol
procedure
production
therapeutic properties
valuable therapeutic
Prior art date
Application number
SE7300471A
Other languages
English (en)
Swedish (sv)
Inventor
C A Demerson
L G Humber
A A Asselin
I L Jirkovsky
G Santroch
T A Dobson
K Pelz
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00217627A external-priority patent/US3852285A/en
Priority claimed from US00226287A external-priority patent/US3833575A/en
Priority claimed from US297130A external-priority patent/US3904617A/en
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of SE392274B publication Critical patent/SE392274B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/02Thiols having mercapto groups bound to acyclic carbon atoms
    • C07C321/10Thiols having mercapto groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7300471A 1972-01-13 1973-01-12 Forfarande for framstellning av indol- och indenderivat med verdefulla terapeutiska egenskaper och med lag toxicitet SE392274B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US00217627A US3852285A (en) 1972-01-13 1972-01-13 Pyrano- and thiopyranoindole derivatives
US00226287A US3833575A (en) 1972-02-14 1972-02-14 Oxazinoindole-and thiazinoindole derivatives
US29712972A 1972-10-12 1972-10-12
US297130A US3904617A (en) 1972-10-12 1972-10-12 Process for preparing new heterocyclic derivatives

Publications (1)

Publication Number Publication Date
SE392274B true SE392274B (sv) 1977-03-21

Family

ID=27499082

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7300471A SE392274B (sv) 1972-01-13 1973-01-12 Forfarande for framstellning av indol- och indenderivat med verdefulla terapeutiska egenskaper och med lag toxicitet

Country Status (7)

Country Link
BE (1) BE793978A (US07923587-20110412-C00001.png)
CH (3) CH606030A5 (US07923587-20110412-C00001.png)
DK (1) DK141201B (US07923587-20110412-C00001.png)
IL (1) IL41130A (US07923587-20110412-C00001.png)
NL (1) NL7300518A (US07923587-20110412-C00001.png)
SE (1) SE392274B (US07923587-20110412-C00001.png)
SU (1) SU728716A3 (US07923587-20110412-C00001.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1683521A1 (en) * 2005-01-21 2006-07-26 Centre National De La Recherche Scientifique (Cnrs) Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CH606030A5 (US07923587-20110412-C00001.png) 1978-10-13
CH606031A5 (US07923587-20110412-C00001.png) 1978-10-13
CH605959A5 (en) 1978-10-13
IL41130A0 (en) 1973-02-28
SU728716A3 (ru) 1980-04-15
BE793978A (fr) 1973-07-12
DK141201B (da) 1980-02-04
DK141201C (US07923587-20110412-C00001.png) 1980-07-28
NL7300518A (US07923587-20110412-C00001.png) 1973-07-17
IL41130A (en) 1976-05-31

Similar Documents

Publication Publication Date Title
SE387122B (sv) Forfarande for framstellning av pyrano(3,4-b)indol- eller tiopyrano(3,4-b)indolderivat med terapeutisk verkan
NO780402L (no) Fremgangsmaate ved fremstilling av benzodiazepinderivater
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE390610B (sv) Forfarande for framstellning av formar och matriser av legeringar
SE413244B (sv) Forfarandefor framstellning av bensopyraner med analgetisk verkan
SE397523B (sv) Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE386678B (sv) Forfarande for framstellning av fluoranderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE385005B (sv) Forfarande for framstellning av substituerade pyrrolidinmetanoler med terapeutisk verkan
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE392274B (sv) Forfarande for framstellning av indol- och indenderivat med verdefulla terapeutiska egenskaper och med lag toxicitet
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE396595B (sv) Forfarande for framstellning av difenylamin och derivat derav
SE398230B (sv) Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
IL43686A0 (en) The production of certain indole derivatives
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
SE402914B (sv) Forfarande for framstellning av 6-metyl-2h-pyran-2,4 (3h)-dion-derivat med hypotensiv verkan
SE7510790L (sv) Forfarande for framstellning av 2- eller 3-cefemderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat